[The effect of propranolol, lisinopril, prednisolone, colchicine, etoposide and vincristine on proliferation of re-stenosing human plaque cells in vitro: cell culture as a prescreening system for prevention of restenosis].
Voisard
R
R
Medizinische Klinik IV, Universität Ulm.
Seitzer
U
U
Dartsch
P C
PC
Roth
D
D
Osterhues
H
H
Kochs
M
M
Hombach
V
V
D000800:Angioplasty, Balloon; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001161:Arteriosclerosis / Q000473:pathology*; D017073:Atherectomy; D002455:Cell Division / Q000187:drug effects*; D002478:Cells, Cultured; D003078:Colchicine / Q000494:pharmacology*; D004151:Dipeptides / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005047:Etoposide / Q000494:pharmacology*; D006801:Humans; D017706:Lisinopril; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000473:pathology; D011239:Prednisolone / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D012008:Recurrence; D014750:Vincristine / Q000494:pharmacology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D004151:Dipeptides; D014750:Vincristine; D005047:Etoposide; D011239:Prednisolone; D011433:Propranolol; D017706:Lisinopril; D003078:Colchicine
Der Effekt von Propranolol, Lisinopril, Prednisolon, Colchizin, Etoposid und Vincristin auf die Proliferation von restenosierenden Plaquezellen des Menschen in Vitro: Zellkultur als Prescreening-System zur Restenose-Prophylaxe.